2019
DOI: 10.1074/mcp.ra118.000904
|View full text |Cite
|
Sign up to set email alerts
|

Modification of Crocodile Spermatozoa Refutes the Tenet That Post-testicular Sperm Maturation Is Restricted To Mammals*

Abstract: Competition to achieve paternity has contributed to the development of a multitude of elaborate male reproductive strategies. In one of the most well-studied examples, the spermatozoa of all mammalian species must undergo a series of physiological changes, termed capacitation, in the female reproductive tract prior to realizing their potential to fertilize an ovum. However, the evolutionary origin and adaptive advantage afforded by capacitation remains obscure. Here, we report the use of comparative and quanti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
47
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

4
5

Authors

Journals

citations
Cited by 38 publications
(49 citation statements)
references
References 48 publications
0
47
0
Order By: Relevance
“…In the context of spermatozoa, the compartmentalization of cAMP signaling machinery coordinated by AKAP4 serves to regulate the specificity of signal transduction pathways responsible for the development, activation and maintenance of motility (Luconi et al, 2011;Sergeant et al, 2019). In accordance with this fundamental role, AKAP4 expression displays high evolutionary conservation, with Akap4 transcripts and/or immunoreactive orthologs of AKAP4 having been characterized in the testes and spermatozoa of species as phylogenetically diverse as eutherian mammals (humans, rodents, bovine, equine, porcine) (Johnson et al, 1997;Turner et al, 1998;Moss et al, 1999;Teijeiro and Marini, 2012;Blommaert et al, 2019;Sergeant et al, 2019), marsupials (tammar wallaby, opossum) (Hu et al, 2009), monotremes (platypus) (Hu et al, 2009), and reptiles (crocodile) (Nixon et al, 2019).…”
Section: Discussionmentioning
confidence: 96%
“…In the context of spermatozoa, the compartmentalization of cAMP signaling machinery coordinated by AKAP4 serves to regulate the specificity of signal transduction pathways responsible for the development, activation and maintenance of motility (Luconi et al, 2011;Sergeant et al, 2019). In accordance with this fundamental role, AKAP4 expression displays high evolutionary conservation, with Akap4 transcripts and/or immunoreactive orthologs of AKAP4 having been characterized in the testes and spermatozoa of species as phylogenetically diverse as eutherian mammals (humans, rodents, bovine, equine, porcine) (Johnson et al, 1997;Turner et al, 1998;Moss et al, 1999;Teijeiro and Marini, 2012;Blommaert et al, 2019;Sergeant et al, 2019), marsupials (tammar wallaby, opossum) (Hu et al, 2009), monotremes (platypus) (Hu et al, 2009), and reptiles (crocodile) (Nixon et al, 2019).…”
Section: Discussionmentioning
confidence: 96%
“…This suggestion is consistent with the term's application by many contemporary reproductive biologists, and underlies the commonly proferred opinion that capacitation is a phenomenon predominantly restricted to mammals (e.g. Nixon et al ., , ). This explicitly restrictive use of ‘capacitation’ will avoid confusion that has arisen by some studies applying the term more generally to PEMS.…”
Section: Defining Pems and Suggested Nomenclaturementioning
confidence: 99%
“…Like AML blast cells, LSCs require mutations in genes encoding for signaling proteins and transcription factors to promote overt AML [105,106]. Furthermore, LSCs are more chemoresistant than AML blast cells [26] making their characterization an important research endeavor.…”
Section: Relapse and Resistance Is Common In Flt3-itd Amlmentioning
confidence: 99%
“…Indeed, in 2017 the FDA approved the FLT3 inhibitor, Midostaurin in combination with standard of care chemotherapy for treatment of newly diagnosed FLT3-mutant AML patients [21], superseding an era of very little advancement in AML therapy [22].Despite the recurrence of FLT3 activating mutations in AML, the differences in oncogenic pathways in patients harboring either ITD or TKD mutations still requires clarification. The significant advancements recently made in unbiased quantitative phosphoproteomic profiling [23][24][25][26] has the potential to provide us with a full annotation of the signal pathways regulated in response to individual mutations, or following acquired resistance induced by 'dual lesions' (e.g. FLT3-ITD-TKD) [27].…”
mentioning
confidence: 99%